RN
Raman Narasinham Akella
About Raman Narasinham Akella
Data last updated:
Raman Narasinham Akella has 19 years in corporate governance. Holds Director role. Formerly with 5 companies, such as Nektar Therapeutics (India) Private Limited and Nishved Retail Markets Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Nektar Therapeutics (India) Private Limited U24239TG2005FTC046253 | Whole-Time Director | 14 Feb 2008 | 2005 | Active |
 Nishved Retail Markets Private Limited U52100TG2008PTC060932 | Director | 09 Sep 2008 | 2008 | Strike Off |
| Widereach Health Solutions Private Limited U85100TG2008PTC061165 | Director | 23 Sep 2008 | 2008 | Strike Off |
| Niche Labs Private Limited U24233AP2008PTC057152 | Director | 15 Jan 2008 | 2008 | Strike Off |
| Vsr Constructions And Property Developers Private Limited U45200TG2005PTC046901 | Director | 01 Apr 2007 | 2005 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raman Narasinham Akella
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raman Narasinham Akella
Raman Narasinham Akella has 19 years in corporate governance. Holds Director role. Formerly with 5 companies, such as Nektar Therapeutics (India) Private Limited and Nishved Retail Markets Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Raman Narasinham Akella is associated with 0 companies as Director.
Raman Narasinham Akella has expertise in General Business, Healthcare.
Raman Narasinham Akella has 19 years in corporate governance.